Benedikt Julian Nicolaus von Thungen-Reichenbach-Evans

Eleva GmbH develops biotechnology products and services. It offers Moss-aGal, Moss-GBA, Moss-FH, contract development and production, developmental pipeline, and technology transfer. The company was founded by Ralf Reski and Gunther Neuhaus in 1999 and is headquartered in Heilbronn, Germany.

Renewable Zukunft was formed in 2006 by six, UK based, farmers and agribusiness specialists who, as primary producers, were keen to explore the role of agriculture in the production of energy from sustainable resources. After in-depth investigation of the renewables market in mainland Europe and the United States, they decided to introduce the best technologies that they had found into the UK. Since then they have put together an impressive portfolio of unique systems and applications covering a broad spectrum of renewable energy technologies. The company's product and their applications have been selected to provide innovative, practical solutions and opportunities for private individuals, companies, local authorities and government agencies who wish to become involved in producing renewable energy. All their systems can be provided as 'turn-key' projects and offer flexible levels of financial and operational involvement from their customers.

Cantab Research Ltd. provides speech and automatic speech recognition technology. It offers batch virtualized ASR, batch containerized ASR, real time virtual appliance, private cloud and elastic ASR, and cloud transcription services. The company was founded by Anthony J. Robinson in 2009 and is headquartered in Cambridge, the United Kingdom.

Selvedge Innovation LLP (Selvedge Venture) is a venture capital firm founded in 2019 by Alasdair Thong and Robert Thong. The firm is headquartered in London, United Kingdom.

Sanome Ltd is a British biotechnology company founded in 2021. The company is based in Cambridge, UK and has subsidiaries in United Kingdom. Sanome engages in research and development of biotechnology.

Syntensor Ltd is a British company that develops machine learning methods combined with first-principles thinking in biology to assist drug developers, clinicians, and physicians in answering fundamental questions. The company was founded by Clayton Rabideau and Rosie Higgins, with Clayton Rabideau serving as CEO since incorporation.